NCT01362361 2019-09-19
AIO-KRK-0111
Martin-Luther-Universität Halle-Wittenberg
Phase 2 Completed
Clinical Trials
3 trialsNCT00801294 2017-12-29
A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer
Boehringer Ingelheim
Phase 2 Completed
NCT00904839 2015-02-04
BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer
Boehringer Ingelheim
Phase 2 Completed